Robert C Detch, MD
Orthopedic Surgery · Burlingame
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: 053193 · Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Detch’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A86859 · Current
Licensed to practise in California · since 2004 · expires 2028-04-30 · New York University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$253,099
Medicare paid this office $253,099 for 646 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Replacement of thigh bone and hip joint with prosthesis | 54 | $63,784 | $1,160 |
| Replacement of knee joint, both sides of knee | 38 | $45,771 | $1,174 |
| Short return visit (20+ min) | 339 | $37,731 | $80 |
| Aspiration and/or injection of fluid from large joint | 221 | $23,768 | $66 |
| New patient visit (30+ min) | 208 | $19,885 | $96 |
See all 13 services
| Replacement of thigh bone and hip joint with prosthesis | 54 | $63,784 | $1,160 |
| Replacement of knee joint, both sides of knee | 38 | $45,771 | $1,174 |
| Short return visit (20+ min) | 339 | $37,731 | $80 |
| Aspiration and/or injection of fluid from large joint | 221 | $23,768 | $66 |
| New patient visit (30+ min) | 208 | $19,885 | $96 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 25 | $10,030 | None |
| Return visit (30+ min) | 62 | $6,889 | $111 |
| Short return visit | 114 | $5,854 | $46 |
| New patient visit (45+ min) | 41 | $5,701 | $139 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $2,628 | $138 |
| Injection, methylprednisolone acetate, 1 mg | 82 | $433 | None |
| Injection, methylprednisolone acetate, 40 mg | 25 | $124 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 129 | $56 | None |
Procedures Medicare counted
| Hip replacement | 60 | More than 91% of doctors who do this |
| Knee replacement | 41 | More than 73% of doctors who do this |
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 1-10 | None |
Who their Medicare patients are
646 Original Medicare patients in 2024. Average age 77 · Under 65 2% · 85 and older 16% · Women 66% · Also on Medicaid 4% · Health risk score 0.91. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 67% · Diabetes 23% · Coronary heart disease 19% · Chronic kidney disease 19% · Atrial fibrillation 16% · Cancer 15% · Depression 15% · Heart failure 12% · COPD 10% · Dementia 5% · Stroke 4%.
The office billed $1,225,291, Medicare allowed $331,289 and paid $253,099; for 6,718 services of 40 kinds; $15,379 of it was for drugs given in the office and $237,720 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 646 | 6,718 | 77 | 0.91 | $1,225,291 | $253,099 |
| 2023 | 523 | 2,104 | 76 | 1.02 | $1,060,501 | $228,302 |
| 2022 | 611 | 2,484 | 77 | 1.05 | $1,085,734 | $243,327 |
| 2021 | 643 | 2,787 | 76 | 1.02 | $1,208,834 | $283,490 |
| 2020 | 590 | 2,169 | 76 | 1.11 | $907,827 | $206,045 |
| 2019 | 758 | 2,775 | 76 | 1.10 | $1,106,629 | $256,663 |
| 2018 | 638 | 1,863 | 77 | 1.17 | $946,078 | $216,796 |
| 2017 | 541 | 1,702 | 77 | 1.17 | $893,602 | $208,787 |
| 2016 | 576 | 1,816 | 76 | 1.39 | $957,873 | $227,493 |
| 2015 | 458 | 2,084 | 76 | 1.19 | $780,142 | $191,431 |
| 2014 | 408 | 1,526 | 77 | 1.11 | $692,477 | $163,268 |
| 2013 | 368 | 1,787 | 77 | 1.18 | $625,681 | $150,626 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Replacement of thigh bone and hip joint with prosthesis | 59 | $69,529 | $1,159 |
| Replacement of knee joint, both sides of knee | 40 | $47,539 | $1,188 |
| Short return visit (20+ min) | 269 | $27,990 | $81 |
| Aspiration and/or injection of fluid from large joint | 174 | $18,688 | $70 |
| New patient visit (30+ min) | 122 | $12,141 | $100 |
| Return visit (30+ min) | 90 | $10,288 | $111 |
| New patient visit (45+ min) | 56 | $7,591 | $136 |
| Short return visit | 59 | $3,286 | $51 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,621 | $147 |
| Injection, methylprednisolone acetate, 40 mg | 80 | $715 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 96 | $48 | None |
2022: 14 services
| Replacement of thigh bone and hip joint with prosthesis | 59 | $69,592 | $1,160 |
| Short return visit (20+ min) | 355 | $37,711 | $77 |
| Replacement of knee joint, both sides of knee | 28 | $34,280 | $1,143 |
| Aspiration and/or injection of fluid from large joint | 185 | $17,717 | $65 |
| New patient visit (30+ min) | 154 | $14,480 | $94 |
| Return visit (30+ min) | 98 | $11,184 | $108 |
| New patient visit (45+ min) | 75 | $10,243 | $137 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 16 | $6,009 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,370 | $177 |
| Short return visit | 26 | $1,521 | $54 |
| Injection of drug or substance under skin or into muscle | 60 | $800 | $13 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 26 | $278 | None |
| Injection, methylprednisolone acetate, 40 mg | 25 | $168 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 130 | $61 | None |
2021: 15 services
| Replacement of knee joint, both sides of knee | 41 | $48,944 | $1,194 |
| Replacement of thigh bone and hip joint with prosthesis | 38 | $47,304 | $1,183 |
| Return visit (30+ min) | 289 | $41,617 | $113 |
| Short return visit (20+ min) | 249 | $27,393 | $81 |
| New patient visit (45+ min) | 135 | $19,474 | $144 |
| Aspiration and/or injection of fluid from large joint | 201 | $18,199 | $66 |
| New patient visit (30+ min) | 86 | $9,028 | $105 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 16 | $6,086 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 30 | $5,412 | $180 |
| Long return visit (40+ min) | 17 | $2,604 | $145 |
| New patient visit (60+ min) | 11 | $1,797 | $163 |
| Aspiration and/or injection of fluid from medium joint | 18 | $989 | $49 |
| Injection of drug or substance under skin or into muscle | 45 | $680 | $14 |
| Injection, methylprednisolone acetate, 40 mg | 79 | $438 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 122 | $80 | None |
2020: 12 services
| Replacement of thigh bone and hip joint with prosthesis | 39 | $50,458 | $1,261 |
| Replacement of knee joint, both sides of knee | 32 | $41,261 | $1,250 |
| Short return visit (20+ min) | 347 | $33,116 | $62 |
| Aspiration and/or injection of fluid from large joint | 192 | $15,825 | $57 |
| New patient visit (30+ min) | 148 | $12,789 | $86 |
| Return visit (30+ min) | 111 | $9,289 | $83 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $4,835 | $179 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 12 | $3,758 | None |
| New patient visit (45+ min) | 27 | $3,578 | $133 |
| Injection, methylprednisolone acetate, 40 mg | 84 | $537 | None |
| Short return visit | 16 | $532 | $33 |
| Injection, dexamethasone sodium phosphate, 1 mg | 111 | $55 | None |
2019: 12 services
| Replacement of thigh bone and hip joint with prosthesis | 44 | $54,313 | $1,207 |
| Short return visit (20+ min) | 424 | $42,999 | $64 |
| Replacement of knee joint, both sides of knee | 27 | $33,261 | $1,232 |
| Aspiration and/or injection of fluid from large joint | 277 | $23,217 | $57 |
| New patient visit (30+ min) | 215 | $19,639 | $91 |
| Return visit (30+ min) | 146 | $14,489 | $92 |
| New patient visit (45+ min) | 92 | $12,337 | $134 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 11 | $6,935 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $4,923 | $182 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 12 | $4,031 | None |
| Injection, methylprednisolone acetate, 40 mg | 163 | $1,026 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 128 | $63 | None |
2018: 11 services
| Replacement of thigh bone and hip joint with prosthesis | 38 | $46,199 | $1,216 |
| Replacement of knee joint, both sides of knee | 30 | $36,048 | $1,202 |
| Short return visit (20+ min) | 338 | $30,529 | $61 |
| Aspiration and/or injection of fluid from large joint | 198 | $16,986 | $58 |
| New patient visit (30+ min) | 156 | $14,076 | $90 |
| New patient visit (45+ min) | 91 | $12,711 | $140 |
| Return visit (30+ min) | 129 | $12,412 | $91 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 17 | $6,444 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $5,941 | $180 |
| Injection, methylprednisolone acetate, 40 mg | 178 | $1,368 | None |
| Short return visit | 14 | $623 | $42 |
2017: 11 services
| Replacement of knee joint, both sides of knee | 33 | $43,308 | $1,237 |
| Replacement of thigh bone and hip joint with prosthesis | 32 | $39,754 | $1,205 |
| Short return visit (20+ min) | 313 | $30,186 | $61 |
| Aspiration and/or injection of fluid from large joint | 159 | $14,737 | $59 |
| New patient visit (30+ min) | 152 | $13,373 | $88 |
| Return visit (30+ min) | 115 | $11,606 | $93 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 16 | $6,419 | None |
| New patient visit (45+ min) | 47 | $6,233 | $133 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,427 | $180 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 31 | $1,589 | $51 |
| Injection, methylprednisolone acetate, 40 mg | 150 | $981 | None |
2016: 11 services
| Replacement of thigh bone and hip joint with prosthesis | 41 | $50,271 | $1,226 |
| Replacement of knee joint, both sides of knee | 35 | $44,276 | $1,197 |
| Short return visit (20+ min) | 323 | $30,249 | $61 |
| New patient visit (30+ min) | 163 | $15,254 | $94 |
| Aspiration and/or injection of fluid from large joint | 156 | $13,383 | $58 |
| Return visit (30+ min) | 105 | $10,099 | $94 |
| New patient visit (45+ min) | 60 | $7,938 | $132 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 19 | $6,868 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $5,101 | $176 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 20 | $1,077 | $51 |
| Injection, methylprednisolone acetate, 40 mg | 140 | $745 | None |
2015: 13 services
| Replacement of thigh bone and hip joint with prosthesis | 29 | $34,833 | $1,201 |
| Short return visit (20+ min) | 252 | $28,887 | $66 |
| Replacement of knee joint, both sides of knee | 21 | $28,603 | $1,244 |
| Aspiration and/or injection of fluid from large joint | 155 | $15,199 | $56 |
| New patient visit (30+ min) | 135 | $13,437 | $100 |
| Return visit (30+ min) | 90 | $10,035 | $99 |
| New patient visit (45+ min) | 58 | $8,916 | $154 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 20 | $8,490 | None |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 11 | $6,393 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $3,232 | $190 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 29 | $1,616 | $54 |
| Short return visit | 19 | $900 | $36 |
| Injection, methylprednisolone acetate, 40 mg | 141 | $531 | None |
2014: 12 services
| Replacement of knee joint, both sides of knee | 22 | $24,317 | $1,057 |
| Short return visit (20+ min) | 178 | $19,229 | $64 |
| Replacement of thigh bone and hip joint with prosthesis | 19 | $19,079 | $1,004 |
| New patient visit (30+ min) | 150 | $13,990 | $93 |
| Aspiration and/or injection of fluid from large joint | 115 | $12,726 | $52 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 22 | $11,877 | None |
| Return visit (30+ min) | 66 | $6,496 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,961 | $180 |
| New patient visit (45+ min) | 23 | $3,379 | $147 |
| Short return visit | 45 | $2,259 | $42 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 21 | $1,114 | $51 |
| Injection, methylprednisolone acetate, 40 mg | 98 | $314 | None |
2013: 15 services
| Replacement of knee joint, both sides of knee | 19 | $22,627 | $1,191 |
| Short return visit (20+ min) | 166 | $18,845 | $65 |
| Replacement of thigh bone and hip joint with prosthesis | 13 | $14,480 | $1,114 |
| Treatment of broken neck of thigh bone with bone implant | 12 | $11,400 | $950 |
| New patient visit (30+ min) | 121 | $11,020 | $91 |
| Aspiration and/or injection of fluid from large joint | 112 | $9,385 | $50 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 13 | $6,811 | None |
| Return visit (30+ min) | 42 | $4,277 | $95 |
| New patient visit (45+ min) | 26 | $3,799 | $146 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,777 | $118 |
| New patient visit (15+ min) | 12 | $783 | $65 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 14 | $709 | $51 |
| Emergency department visit with low level of medical decision making | 13 | $668 | $51 |
| Short return visit | 12 | $634 | $40 |
| Injection, methylprednisolone acetate, 40 mg | 98 | $325 | None |
Drugs they prescribed that Part D paid
$5,309
Pharmacies billed $5,309 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 27% of their Part D prescriptions (37 of 139) in 2024. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 31%.
128 generic and 11 brand-name prescriptions · $5,309 in drug cost · 53 antibiotic prescriptions to 43 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 11 | $4,098 | $373 |
| Hydrocodone-Acetaminophen | 31 | $255 | $8 |
| Amoxicillin | 44 | $67 | $2 |
| Meloxicam | 14 | $34 | $2 |
Year by year
| 2024 | 139 | 97 | 27% (37) | 8% | $5,309 |
| 2023 | 220 | 141 | 35% (77) | 28% | $19,109 |
| 2022 | 232 | 134 | 33% (77) | 19% | $12,510 |
| 2021 | 176 | 101 | 31% (54) | 6% | $3,346 |
| 2020 | 183 | 98 | 19% (34) | None | $2,851 |
| 2019 | 289 | 128 | 21% (60) | None | $4,378 |
| 2018 | 384 | 172 | 37% (141) | 7% | $7,991 |
| 2017 | 446 | 175 | 31% (140) | 5% | $10,164 |
| 2016 | 442 | 162 | 23% (102) | 7% | $11,854 |
| 2015 | 418 | 171 | 31% (129) | 6% | $8,359 |
| 2014 | 349 | 143 | 33% (116) | 19% | $11,082 |
| 2013 | 245 | 106 | 33% (80) | 11% | $6,353 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Eliquis | 61 | $17,952 | $294 |
| Hydrocodone-Acetaminophen | 41 | $288 | $7 |
| Meloxicam | 26 | $150 | $6 |
| Tramadol | 16 | $50 | $3 |
| Amoxicillin | 25 | $47 | $2 |
| Oxycodone | 12 | $41 | $3 |
2022: 6 drugs
| Eliquis | 43 | $11,137 | $259 |
| Hydrocodone-Acetaminophen | 48 | $354 | $7 |
| Diclofenac | 14 | $340 | $24 |
| Meloxicam | 50 | $220 | $4 |
| Tramadol | 17 | $62 | $4 |
| Amoxicillin | 19 | $60 | $3 |
2021: 7 drugs
| Eliquis | 11 | $2,382 | $217 |
| Meloxicam | 65 | $339 | $5 |
| Diclofenac | 11 | $184 | $17 |
| Hydrocodone-Acetaminophen | 26 | $174 | $7 |
| Oxycodone | 12 | $92 | $8 |
| Amoxicillin | 21 | $59 | $3 |
| Tramadol | 15 | $37 | $2 |
2020: 4 drugs
| Diclofenac | 37 | $839 | $23 |
| Meloxicam | 72 | $463 | $6 |
| Hydrocodone-Acetaminophen | 23 | $178 | $8 |
| Amoxicillin | 16 | $45 | $3 |
2019: 6 drugs
| Diclofenac | 56 | $1,768 | $32 |
| Meloxicam | 114 | $605 | $5 |
| Hydrocodone-Acetaminophen | 35 | $355 | $10 |
| Oxycodone | 15 | $190 | $13 |
| Cephalexin | 16 | $79 | $5 |
| Amoxicillin | 15 | $58 | $4 |
2018: 10 drugs
| Eliquis | 15 | $3,062 | $204 |
| Hydrocodone-Acetaminophen | 82 | $872 | $11 |
| Diclofenac | 31 | $799 | $26 |
| Meloxicam | 125 | $669 | $5 |
| Oxycodone-Acetaminophen | 13 | $212 | $16 |
| Tramadol | 33 | $151 | $5 |
| Oxycodone | 13 | $130 | $10 |
| Gabapentin | 14 | $95 | $7 |
| Cephalexin | 16 | $80 | $5 |
| Amoxicillin | 17 | $53 | $3 |
2017: 11 drugs
| Piroxicam | 21 | $1,922 | $92 |
| Meloxicam | 155 | $951 | $6 |
| Diclofenac | 31 | $868 | $28 |
| Hydrocodone-Acetaminophen | 62 | $375 | $6 |
| Oxycodone | 22 | $281 | $13 |
| Tramadol | 37 | $202 | $5 |
| Cyclobenzaprine | 12 | $182 | $15 |
| Oxycodone-Acetaminophen | 12 | $158 | $13 |
| Gabapentin | 14 | $90 | $6 |
| Cephalexin | 16 | $74 | $5 |
| Amoxicillin | 14 | $34 | $2 |
2016: 11 drugs
| Piroxicam | 35 | $2,825 | $81 |
| Diclofenac | 35 | $1,078 | $31 |
| Meloxicam | 149 | $853 | $6 |
| Hydrocodone-Acetaminophen | 35 | $653 | $19 |
| Tramadol | 35 | $239 | $7 |
| Oxycodone-Acetaminophen | 12 | $234 | $20 |
| Oxycodone | 15 | $202 | $13 |
| Naproxen | 16 | $167 | $10 |
| Cephalexin | 34 | $152 | $4 |
| Cyclobenzaprine | 14 | $80 | $6 |
| Amoxicillin | 17 | $68 | $4 |
2015: 9 drugs
| Piroxicam | 37 | $2,492 | $67 |
| Voltaren | 21 | $983 | $47 |
| Meloxicam | 155 | $747 | $5 |
| Hydrocodone-Acetaminophen | 46 | $720 | $16 |
| Oxycodone | 32 | $420 | $13 |
| Diclofenac | 15 | $237 | $16 |
| Tramadol | 42 | $174 | $4 |
| Naproxen | 11 | $96 | $9 |
| Cephalexin | 18 | $44 | $2 |
2014: 6 drugs
| Piroxicam | 52 | $3,109 | $60 |
| Voltaren | 57 | $2,342 | $41 |
| Hydrocodone-Acetaminophen | 80 | $1,019 | $13 |
| Meloxicam | 55 | $325 | $6 |
| Tramadol | 18 | $118 | $7 |
| Cyclobenzaprine | 11 | $44 | $4 |
2013: 7 drugs
| Piroxicam | 20 | $1,284 | $64 |
| Diclofenac | 45 | $1,123 | $25 |
| Voltaren | 20 | $773 | $39 |
| Hydrocodone-Acetaminophen | 47 | $593 | $13 |
| Meloxicam | 21 | $176 | $8 |
| Naproxen | 18 | $149 | $8 |
| Tramadol | 15 | $120 | $8 |
Money from drug and device companies
$243 in 2025
| 2025 | 1 | 1 | None | $243 |
| 2023 | 1 | 6 | None | $1,174 |
| 2021 | 1 | 1 | None | $22 |
| 2019 | 2 | 6 | None | $467 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Stryker | Mako | $243 | 1 payment
|
See the published payment
| Stryker | Travel · 2025-02-28 | Mako | $243 |
See earlier years (2023, 2021, 2019)
2023: $1,174
| Smith+Nephew | Real Intelligence | $1,174 | 6 payments
|
2021: $22
| Smith+Nephew | Cori | $22 | 1 payment
|
2019: $467
| Smith+Nephew | Journey II Bcs | $289 | 4 payments
|
| Stryker | Mako | $178 | 2 payments
|
Professional record
- NPI
- 1558493189
- Licence
- CA A86859California A86859: Current · expires 2028-04-30
- Trained
- New York University School of Medicine, 2002
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Orthopedic surgery (207X00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2007-03-09
- NPI last updated
- 2020-06-22
- NPI record certified
- 2020-06-22
This is when the NPI record was last certified, not a medical board exam.